Novartis – Up to 3,000 job cuts in just 4 months

Unlike every other Big Pharma company in the world, Novartis ($NVS) tends to prefer to communicate rather selectively when it chops a facility here or winnows out its ranks over there in its global structure. Specifics on the secretive Basel-based company tend to leak out through local reports, if at all, with releases targeted at publications specifically located in the area where the ax is falling. And Novartis rarely explains itself or adds detail where a simple, dismissive remark will do.

Confronted by the corporate stone wall, an enterprising reporter at Switzerland’s Tages-Anzeiger tallied up 3,000 job cuts Novartis has announced at various sites around the globe over the last 4 months. Close to a thousand of those jobs are being axed in Europe; half in the corporation’s Basel home. There’s the 400 or so confirmed layoffs in its Horsham, U.K., R&D site, not to mention some 170 consultants, often overlooked when job losses are added up.

via Report: Novartis reorganization quietly claims 3,000 jobs in just 4 months – FierceBiotech.

Related articles

• Novartis / To cut or transfer up to 4,000 jobs
• Novartis / To shuffle and cut jobs
• Novartis (Ciba Vision) / To cut 300 jobs with closure in Mississauga
• Merck / To cut 8,500 jobs
• Pharmaceutical / The Skills Gap
• Layoffs in Pharmaceutical Industry / Due to Productivity Crisis in R&D ?
• Teva / The drug company to cut 5,000 jobs
• Layoffs in Pharmaceuticals / The top 10 largest in 2013